Europe Embolization Coils Market

The Europe embolization coils market is expected to grow from US$ 310.02 million in 2022 to US$ 391.22 million by 2028; it is estimated to grow at a CAGR of 4.0% from 2022 to 2028.

Escalation in Patient Preference for Minimally Invasive Procedures

The number of minimally invasive surgeries is rising as patients increasingly prefer such surgeries due to lesser postoperative pain, postoperative complications, shorter hospital stays, fast recovery times, etc. Noninvasive or minimally invasive treatments are being developed as alternatives to surgery for patients with early-stage breast cancer. For instance, Trans Arterial Chemo Embolization, also known as TACE, is a minimally invasive procedure that is typically used to treat hepatocellular carcinoma. TACE is for patients with asymptomatic and unresectable liver cancer. TACE can be used to diminish the size of the tumor and make the patient eligible for liver transplantation. It is considered an evolution from a formerly applied technique called Trans-Catheter Arterial Embolization (TAE). Bleeding is a common issue in cancer patients, related to local tumor invasion, tumor angiogenesis, systemic effects of cancer, or anti-cancer treatments. TACE involves a two-step process—selective arterial occlusion restricts the blood supply to the tumor, which causes ischemic tumor necrosis, and regional chemotherapy is arranged that helps the drug to remain in the area for a prolonged period, which starts causing the therapeutic effects. Prostatic artery embolization (PAE) is also a minimally invasive therapy implemented as an elective outpatient technique for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The number of patients treated with PAE has grown in recent years. Thus, the increasing preference for minimally invasive procedures is fueling the embolization coils market growth. In Addition, the rise in the awareness about minimally invasive procedures and availability of the reimbursement for minimally invasive procedures are likely to foster the demand for a minimally invasive procedure. Thus, owing to these factors the Europe embolization coils market is likely to propel significantly in the forecast period.

Europe Embolization Coils Market Overview

The Europe embolization coils market includes France, Germany, United Kingdom, Italy, Spain, and Rest of Europe. Europe occupies second position in the global embolization coils market and is expected to register robust growth rate over the forecast period. The market is expected to witness robust growth due to the rising prevalence of the renal cancer in Germany and increasing numbers of the investments by the governments of France and United Kingdom. In addition, the rise in the prevalence of stroke is likely to drive the market significantly in the coming future.

Europe Embolization Coils Market Revenue and Forecast to 2028 (US$ Million)

Europe Embolization Coils Strategic Insights

Strategic insights for the Europe Embolization Coils provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Embolization Coils Report Scope

Europe Embolization Coils Regional Insights

The geographic scope of the Europe Embolization Coils refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Europe Embolization Coils Market Segmentation

The Europe embolization coils market is segmented on the basis of type, material, application, end user, and country. Based on type, the Europe embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2022.

Based on material, the Europe embolization coils market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2022.

Based on application, the Europe embolization coils market is segmented into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. The neurology segment held the largest market share in 2022.

Based on end user, the Europe embolization coils market is segmented into hospital, cardiac center, ambulatory center, and other. The hospital segment held the largest market share in 2022. 

Based on country, the Europe embolization coils market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. The Germany dominated the market share in 2022.

Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker; KANEKA CORPORATION; MicroPort Scientific Corporation; Penumbra, Inc.; Cook Medical LLC; Johnson & Johnson Services, Inc.; and Shape Memory Medical INC. are the leading companies operating in the Europe embolization coils market.